| Nassar Nizami |
Nassar Nizami is currently a Member at Gartner, Inc., a Member at Healthcare Information & Management Systems Society, a Chief Information Officer at EXACT Sciences Corp., a Member at College of Healthcare Information Management Executives, a Member at Information Systems Audit & Control Association, Inc., and a Member at American College of Healthcare Executives. Previously, Mr. Nizami held the position of Chief Information & Digital Officer, Executive VP at The Jefferson Health Plan and Thomas Jefferson University. Mr. Nizami has a graduate degree from the University of Bridgeport and an undergraduate degree from Eastern Mediterranean University. |
| Jeffrey Thomas Elliott |
Jeffrey Thomas Elliott is currently the Chief Financial Officer & Director at Paradigm Diagnostics, Inc. He also holds the position of Executive VP, Chief Operating & Financial Officer at EXACT Sciences Corp. since 2021 and Chief Financial Officer at Genomic Health, Inc. since 2019. Previously, he served as an Independent Director at Exagen, Inc. from 2019 to 2021. He also worked as a Research Associate at Robert W. Baird & Co., Inc. (Broker) in 2007-2008, a Senior Consultant at Capgemini US LLC from 2000 to 2003, and a Senior Business Analyst at Walgreens Health Services, Inc. in 2005. Mr. Elliott holds an MBA from The University of Chicago Booth School of Business and an undergraduate degree from the University of Illinois At Urbana–Champaign, conferred in 2000. |
| Veronica Descotte |
Veronica Descotte is currently the Director at EOS International, Inc. and the Chief Strategy Officer at EXACT Sciences Corp. She previously worked as the Director at PCs for People and as an Associate at Burrill LLC. Ms. Descotte completed her undergraduate degree at Macalester College and holds an MBA from The University of Chicago Booth School of Business. |
| Everett V. Cunningham |
Everett V. Cunningham is currently a Director at American Family Children's Hospital, Visby Medical, Inc., and Arvinas, Inc. He is also the Chief Commercial Officer at EXACT Sciences Corp. Previously, he worked at Pfizer Inc. as President-Established Products from 2011 to 2012 and at Quest Diagnostics, Inc. as Senior Vice President-Commercial from 2012 to 2019. Cunningham received his undergraduate degree from Northwestern University. |
| Tomasz M. Beer |
Tomasz M. Beer is currently working as Co-Chief Medical Officer at EXACT Sciences Corp. and also holds a position as Professor of Hematology & Medical Oncology at Oregon Health & Science University. He completed his undergraduate and graduate studies at The Johns Hopkins University. |
| Sandra Statz |
Presently, Sandra Statz is Senior VP-Clinical & Regulatory Affairs at EXACT Sciences Corp. Ms. Statz is also Member of Regulatory Affairs Professionals Society, Member of Association of Clinical Research Professionals and Member of Medical Device Innovation Consortium.
In the past she occupied the position of Director-Clinical Affairs at Third Wave Technologies, Inc. and Director-Clinical Operations at Quintiles, Inc. (California).
Sandra Statz received an MBA and an undergraduate degree from the University of Wisconsin. |
| Paul J. Limburg |
Paul J. Limburg is currently the Co-Chief Medical Officer & Screening at EXACT Sciences Corp. Prior to this, he worked as the Medical Director-Global Business Solutions at The Mayo Clinic (Old) from 2012 to 2018. He received his undergraduate degree from Augustana College (Illinois), graduate degree from Johns Hopkins Bloomberg School of Public Health, and doctorate from Mayo Medical School. |
| Ana Hooker |
Ana Hooker is an Independent Director at Exagen, Inc. She is also a Director at Big Brothers Big Sisters of Dane County and Overture Center For The Arts. Previously, she worked as the Chief Laboratory Officer at EXACT Sciences Corp. from 2013 to the present. She was also a Vice President & Division Manager-Genetics at Arup Laboratories, Inc. from 2007 to 2013. Ms. Hooker holds an undergraduate degree from Kansas State University and an MBA from Westminster College (Pennsylvania). |
| Frederick Baehner |
Frederick Baehner is currently the Director at UCSF Helen Diller Family Comprehensive Cancer Center and Co-Chief Medical Officer & Precision Oncology at EXACT Sciences Corp. He was formerly the Chief Medical Officer at Genomic Health, Inc. Baehner received his undergraduate and doctorate degrees from the University of Kansas. |
| Sri Kalluri |
Presently, Sri Kalluri occupies the position of Chief Information Officer of EXACT Sciences Corp.
In his past career Mr. Kalluri was Chief Information Officer & Vice President for CEPHEID.
He received an MBA from the University of Southern California and an undergraduate degree from Osmania University. |
| Jorge A. Garces |
Jorge A. Garces is the founder of Idgenetix, Inc. He is currently the Chief Science Officer at EXACT Sciences Corp. since 2021. Previously, he held positions such as Chief Executive Officer at Enigma Diagnostics Ltd. from 2009 to 2012, Director-Molecular Research & Development at Genzyme Genetics, Inc., President, Chief Operating Officer & Director at AltheaDx, Inc. from 2013 to 2017, Vice President & Manager-Site Operations at Hologic, Inc. from 2005 to 2009, Vice President-Research & Development at Third Wave Technologies, Inc., and Associate Product Manager at Blueprint Genetics, Inc. He also served as Senior Vice President-Research & Development at GenMark Diagnostics, Inc. from 2012 to 2013, and as President & Chief Scientific Officer at Epigenomics AG from 2017 to 2021. In terms of education, he obtained an undergraduate degree from Brooklyn College, a doctorate from City University of New York, and an MBA from Kellogg School of Management. |
| Graham Peter Lidgard |
Graham Peter Lidgard is the founder of Matritech, Inc. He is currently the Chief Science Officer & Executive Vice President at EXACT Sciences Corp. since 2009. Previously, he served as the Senior Vice President-Research & Development at Ngen, Inc. from 2003 to 2009 and as the Vice President-Research & Development at Gen-Probe, Inc. from 1995 to 2002. He also held positions as Vice President-Product Development at Ciba Corning Diagnostics Corp. and Vice President-Research & Development at NANOGEN INC. Dr. Lidgard obtained his undergraduate and doctorate degrees from The University of Manchester. |
| Kevin T. Conroy |
Kevin T. Conroy is currently the Chairman, President & Chief Executive Officer at EXACT Sciences Corp. He is also the Chief Executive Officer at Genomic Health, Inc. and a Director at Align Technology, Inc. In addition, he holds positions as President & Director at Paradigm Diagnostics, Inc., Director at Wisconsin Technology Council, Director at American Clinical Laboratory Association, Director at Greater Madison Chamber of Commerce, and Director at Overture Center Foundation. Previously, Mr. Conroy served as the President & Chief Executive Officer at Third Wave Technologies, Inc. from 2005 to 2008. He was also the Chairman at United Way of Dane County, Inc. and a Director at Bioforward, Inc. From 2017 to 2022, he served as an Independent Director at Epizyme, Inc. and from 2019 to 2023, he was an Independent Director at Adaptive Biotechnologies Corp. He also held the position of Independent Director at CM Life Sciences II, Inc. in 2021. Additionally, he served as a Director at Overture Center For The Arts and SomaLogic, Inc. Furthermore, he was an Independent Director at ARYA Sciences Acquisition Corp. from 2018 to 2020. Prior to that, he worked as a Partner at McDermott Will & Emery LLP and Counsel-Intellectual Property at GE Healthcare Ltd. (United Kingdom). He was also a Partner at Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP. Mr. Conroy received his undergraduate degree from Michigan State University and his graduate degree from The University of Michigan Law School. |
| Kathleen Sebelius |
Kathleen Sebelius is the founder of Sebelius Resources LLC. She currently holds several positions including Co-Chairman at The Aspen Institute, Chairman at Humacyte, Independent Director at EXACT Sciences Corp., Director at Humacyte Global, Director at IncludeHealth, Director at Consulting Medical Associates, Director at Roivant Sciences, Director at Devoted Health, Member of The Democratic Party (United States), and Trustee at Kaiser Family Foundation. Previously, she served as an Independent Director at Dermira, Lead Independent Director at Myovant Sciences Ltd., Governor of the State of Kansas, and Secretary of the US Department of Health & Human Services. She also worked as a Senior Advisor at Eat Just, Inc. Ms. Sebelius received an undergraduate degree from Trinity College (District of Columbia) and a graduate degree from the University of Kansas. |
| Freda C. Lewis-Hall |
Dr. Freda C. Lewis-Hall, MD, is an Independent Non-Executive Chairman at Conduit Pharmaceuticals, Inc., an Independent Director at Pyxis Oncology, Inc., an Independent Director at EXACT Sciences Corp., an Independent Director at Springworks Therapeutics, Inc., a Chairman-Cures Acceleration Network Review Board of National Center for Advancing Translational Sciences, a Director-Drug Discovery, Development & Translation at National Academy of Medicine (United States), a Fellow at The Royal College of Physicians and a Venture Partner at Catalio Capital Management LP. She is on the Board of Directors at Pyxis Oncology, Inc., EXACT Sciences Corp., Morris Associates, Inc. (Michigan), Springworks Therapeutics, Inc., Patient-Centered Outcomes Research Institute, American Heart Association, Inc., American Psychiatric Foundation, FasterCures, Foundation for the National Institutes of Health, Inc., Harvard Medical School and SpringWorks Therapeutics LLC. Dr. Lewis-Hall was previously employed as an Independent Director by 1Life Healthcare, Inc., a Chairman by National Minority Supplier Development Council, Inc., an Independent Director by Tenet Healthcare Corp., a Chief Patient Officer & Executive Vice President by Pfizer Inc., an Executive Vice President-Medicines Development by Vertex Pharmaceuticals, Inc., a Senior VP-US Pharmaceuticals & Medical Affairs by Bristol Myers Squibb Co., a Vice President-Product, Research & Development by Pharmacia Corp., a Principal by Eli Lilly & Co., a Vice Chairperson & Associate Professor by Howard University College of Medicine, a Principal by National Institute of Mental Health, and a Trustee by Save The Children Federation Inc. She also served on the board at Society For Women's Health Research. She received her undergraduate degree from The Johns Hopkins University and a doctorate degree from Howard University College of Medicine. |
| Shacey Petrovic |
Shacey Petrovic is currently serving as the Vice Chairman at Ambu A. She is also an Independent Director at EXACT Sciences Corp., a Director at Insulet Corp., a Director at the Advanced Medical Technology Association, a Director at Alydia Health, Inc., and a Director at Imperative Care, Inc. In her former positions, Ms. Petrovic served as the President & Chief Executive Officer at Clinical Innovations LLC from 2013 to 2015. Prior to that, she was the Vice President & GM-GYN Surgical Products Division at Hologic, Inc. from 2000 to 2013, and at Cytyc Corp. from 2000 to 2007. Ms. Petrovic completed her undergraduate degree at the University of Wisconsin in 1996. |
| Katherine Zanotti |
Katherine Zanotti is currently an Independent Director at EXACT Sciences Corp., a Director at Diversey, Inc., a Director at Maple Mountain Group, Inc., a Director at RxDino LLC, and a Trustee at Xavier University. Previously, she served as the Chief Executive Officer at Arbonne International LLC from 2009 to 2018, Chairman at Natural Products Group, Inc. from 2010 to 2018, Director at Mentor Worldwide LLC from 2007 to 2009, Director at Third Wave Technologies, Inc. from 2006 to 2008, Independent Director at Cutera, Inc. from 2019 to 2022, Director at Alberto-Culver LLC from 2006 to 2009, Senior Vice President-Marketing at McDonald's Corp. from 2002 to 2006, and VP & GM-North American Pharmaceutical Business at Procter & Gamble Co. from 1979 to 2002. She holds an MBA from Xavier University and an undergraduate degree from Georgetown University. |
| Paul J. Clancy |
Paul J. Clancy is currently the Chairman at Xilio Therapeutics, Inc., the Independent Chairman at Sionna Therapeutics, Inc., the Independent Director at Incyte Corp., the Independent Director at EXACT Sciences Corp., and holds positions as Secretary, Director & Vice President at Stromedix, Inc. Previously, he served as the President & Director at Bioverativ Therapeutics, Inc., an Independent Director at Agios Pharmaceuticals, Inc., the VP & General Manager-Great West Business Unit at PepsiCo, Inc., the Chief Financial Officer & EVP-Finance at Biogen, Inc., the Chief Financial Officer & Executive Vice President at Biogen Idec New Ventures, Inc., and the Senior Vice President-Finance at Biogen Idec, Inc. (North Carolina). He also held the position of Chief Financial Officer & Executive Vice President at Alexion Pharmaceuticals, Inc. Mr. Clancy received his undergraduate degree from Babson College and his MBA from Columbia Business School. |
| Pierre Jacquet |
Pierre Jacquet is currently the Vice Chairman & MD-Global Healthcare at The Lek, Vice Chairman & MD-Healthcare Practice at L.E.K. Consulting LLC, Independent Director at EXACT Sciences Corp., and Non-Executive Director at Mereo BioPharma Group Plc. Previously, he worked as a Director at Osprey Pharmaceuticals USA, Inc., Head-Business Development at Genzyme Corp., Manager at Arthur D. Little, Inc., and Advisor at Transfer Technologies Commercialisation Capital. He holds a doctorate from the University of Liege and an MBA from the University of Virginia Darden School of Business. |
| Daniel Joseph Levangie |
Daniel Joseph Levangie founded Aton Partners LLC in 2013, where he worked as Managing Partner from 2013 to 2018. Mr. Levangie also founded Constitution Medical, Inc., where he worked as Director & Managing Partner. Mr. Levangie also currently works at CereVasc, Inc., as President & Chief Executive Officer from 2018, EXACT Sciences Corp., as Independent Director from 2010, Rapid Medical Ltd., as Director from 2021, Renalytix Plc, as Independent Non-Executive Director from 2021, and Excel Academy Charter School, as Trustee. Mr. Levangie also formerly worked at Cytyc Corp., as President, Chief Executive Officer & COO from 2002 to 2007, Dune Medical Devices, Inc., as Chief Executive Officer from 2011 to 2013, ev3, Inc., as Non-Executive Chairman from 2007 to 2010, Keystone Dental, Inc., as Chairman, HyperMed, Inc., as Chairman, Hologic, Inc., as Director from 2007 to 2008, LipoScience, Inc., as Independent Director from 2011 to 2014, Renovia, Inc. (MA), as Director, Abbott Laboratories, as Principal, Insulet Corp., as President-Drug Delivery Division from 2015 to 2017, and Roche Diagnostics Hematology, Inc, as Managing Partner in 2008. Mr. Levangie received his undergraduate degree in 1973 from Northeastern University. |
| James Edward Doyle |
Mr. James E. Doyle is a Lead Independent Director at EXACT Sciences Corp. and a Partner at Doyle & Boyce Strategies LLC. He is on the Board of Directors at EXACT Sciences Corp. Mr. Doyle was previously employed as a President by National Association of Attorneys General, a Governor by State of Wisconsin, a District Attorney by County of Dane (Wisconsin), an Of Counsel by Foley & Lardner LLP, and an Attorney by Navajo Nation. He received his undergraduate degree from the University of Wisconsin and a graduate degree from Harvard Law School. |
| Timothy J. Scannell |
Timothy J. Scannell is currently serving as the Chairman at Synaptive Medical, Inc. He is also the Independent Chairman at Insulet Corp., Independent Director at EXACT Sciences Corp., Independent Director at NovoCure Ltd., Director at Collagen Matrix, Inc., Director at Cerebral Therapeutics, Inc., and Independent Director at Molekule Group, Inc. In his former positions, Mr. Scannell served as a Director at Entellus Medical, Inc., Independent Non-Executive Director at Renalytix Plc, Independent Director at AeroClean Technologies, Inc., President & Chief Operating Officer at Stryker Corp., President at Stryker Spine, and Vice President & General Manager at Stryker Biotech LLC. Mr. Scannell completed his undergraduate degree and received an MBA from the University of Notre Dame. |
